Tesamorelin
FDA-approved (Rx)Also known as: Egrifta
Category: Growth hormone
Sold as:
Ameano Peptides: Tesamorelin
Nexaph: Tesamorelin
Growth hormone releasing hormone (GHRH) analog that raises the body's own GH and IGF-1 output.
What it's used for
- Reduction of excess abdominal (visceral) fat in HIV-associated lipodystrophy
- Off-label interest for visceral fat and body composition
Dosing
- Typical dose
- Label dose is about 1.4 to 2 mg once daily depending on formulation.
- How often
- Once daily
- Route
- Subcutaneous injection into the abdomen
- Cycle length
- Label use is continuous. Benefits reverse after stopping.
Build a dosing plan for Tesamorelin →
How to reconstitute and measure a dose → · About bacteriostatic water →
Possible side effects
- Joint pain, swelling, muscle aches
- Injection site redness
- Raised blood sugar
Important: Prescription drug. Not for use in pregnancy or with active cancer.
Also sold in blends
- Tesamorelin/Ipamorelin Blend: Tesamorelin 10 mg + Ipamorelin 3 mg (Ameano Peptides, Nexaph)